Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Enfermedades Infecciosas | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Reclutando
Fase 2
ClinicalTrials.gov
A Prospective, Multi-Centre Study (B-Sure) to Evaluate Long-Term Durability of Treatment Response in Chronic Hepatitis B Participants With and Without Nucleos(t)Ide Therapy Who Have Participated in a Previous Bepirovirsen Treatment Study
INTERVENTIONAL
Inicio: 14 de dic de 2021
ID: NCT04954859
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Study to Evaluate the Efficacy and Safety of Cefepime-AAI101 Compared to Piperacillin/Tazobactam in the Treatment of Complicated Urinary Tract Infections, Including Acute Pyelonephritis.
INTERVENTIONAL
Inicio: 24 de sept de 2018
ID: NCT03687255
Desconocido
ClinicalTrials.gov
Recruitment Assessment in Patients With Acute Respiratory Distress Syndrome and Covid-19
OBSERVATIONAL
Inicio: 7 de mar de 2022
ID: NCT05248243
Completado
ClinicalTrials.gov
Pharmacokinetic Properties of Antiretroviral and Related Drugs During Pregnancy and Postpartum
OBSERVATIONAL
Inicio: 9 de jun de 2003
ID: NCT00042289
Completado
ClinicalTrials.gov
Descriptive Cohort of Acquired Syphlis by Non Sexual Contact
OBSERVATIONAL
Inicio: 15 de jul de 2020
ID: NCT04455425
Completado
Fase 3
ClinicalTrials.gov
Phase III in Partial and Null Responders
INTERVENTIONAL
Inicio: 1 de feb de 2012
ID: NCT01485991
Retirado
Fase 4
ClinicalTrials.gov
Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study
INTERVENTIONAL
Inicio: 22 de may de 2019
ID: NCT05295394
Terminado
Fase 2
ClinicalTrials.gov
A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Effects of EDP-938 in Hematopoietic Cell Transplant Recipients With Acute Respiratory Syncytial Virus Infection of the Upper Respiratory Tract
INTERVENTIONAL
Inicio: 7 de jul de 2021
ID: NCT04633187
Reclutando
Fase 3
ClinicalTrials.gov
A PHASE 3, PLACEBO-CONTROLLED, DOUBLE-BLINDED, RANDOMIZED STUDY TO EVALUATE THE EFFICACY, SAFETY, AND TOLERABILITY OF A CLOSTRIDIOIDES DIFFICILE VACCINE IN ADULTS 65 YEARS OF AGE AND OLDER
INTERVENTIONAL
Inicio: 10 de dic de 2025
ID: NCT07282665
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Favipiravir in Adult Subjects With Uncomplicated Influenza
INTERVENTIONAL
Inicio: 1 de dic de 2013
ID: NCT02008344
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-Blind, Comparative Trial Of A Novel CCR5 Antagonist, UK-427,857, In Combination With Zidovudine/Lamivudine Versus Efavirenz In Combination With Zidovudine/Lamivudine For The Treatment Of Antiretroviral-Naive HIV-1 Infected Subjects
INTERVENTIONAL
Inicio: 1 de nov de 2004
ID: NCT00098293
Completado
ClinicalTrials.gov
Lung Injury (Pulmonary Edema) in COVID-19: Treatment With Furosemide and Negative Fluid Balance (NEGBAL): a Case-Control Study
OBSERVATIONAL
Inicio: 28 de nov de 2021
ID: NCT05304702
Completado
ClinicalTrials.gov
Evaluation of the Relationship Between Non-attendance to Appointments and Adherence to Medical Indications, in Adult Patients, With Type 2 Diabetes Mellitus, During the COVID-19 Pandemic: Cross-sectional Studio.
OBSERVATIONAL
Inicio: 1 de jul de 2020
ID: NCT06501456
Completado
Fase 2
ClinicalTrials.gov
A Two-Part Study With a Birth Cohort (Observational Stage) for Early Diagnosis of Respiratory Syncytial Virus (RSV), Followed by an Optional Phase 2a, Randomized, Double-blind, Placebo-controlled Study (Interventional Stage) to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 in Infants With Acute Respiratory Tract Infection Due to RSV
INTERVENTIONAL
Inicio: 10 de oct de 2019
ID: NCT04068792
Completado
ClinicalTrials.gov
COVID-19 Sequelae: Treatment and Monitoring of Persistent Symptoms, a Decentralized Approach Focus on the Patient. Use of Dietary Supplement Based on Sea Urchin Eggs With Echinochroma A.
INTERVENTIONAL
Inicio: 22 de sept de 2021
ID: NCT05531019
Reclutando
Fase 4
ClinicalTrials.gov
Switch to Dolutegravir Plus Lamivudine Dual-therapy in Transgender Women Living With HIV on Virologically Suppressive Antiretroviral Therapy (TRANS-SWITCH)
INTERVENTIONAL
Inicio: 31 de jul de 2025
ID: NCT06967753
Completado
ClinicalTrials.gov
Clinical and Immunologic Impact of SARS-CoV-2 in Hospitalized Pregnant Women and Neonates in Argentina
OBSERVATIONAL
Inicio: 10 de jul de 2020
ID: NCT04362956
Completado
Fase 3
ClinicalTrials.gov
Phase 3 Randomized, Double-blind, Placebo-controlled Multi-center Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm (RUXCOVID)
INTERVENTIONAL
Inicio: 2 de may de 2020
ID: NCT04362137
Completado
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Multicenter, Open-label, Non-inferiority Study Evaluating the Efficacy, Safety and Tolerability of Switching to Dolutegravir/Lamivudine Fixed Dose Combination in HIV-1 Infected Adults Who Are Virologically Suppressed
INTERVENTIONAL
Inicio: 11 de nov de 2019
ID: NCT04021290
Completado
ClinicalTrials.gov
HIV-1 Subtype-specific Drug Resistance in Patients Failing Dolutegravir-based 1st, 2nd or 3rd Line Regimens: the International Epidemiological Databases to Evaluate AIDS (IeDEA)
OBSERVATIONAL
Inicio: 13 de jun de 2022
ID: NCT06285110
Anterior
1
...
40
41
42
...
434
Siguiente
Filtros